Clinical Trial Results: Severe Asthma, MepolizumaB and Affect: SAMBA Study

View source ↗

Summary

Clinical trial results for SAMBA study evaluating Mepolizumab in severe eosinophilic asthma with psychological distress were completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Asthma

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: University Hospital Southampton NHS Foundation Trust | Conditions: Severe Eosinophilic Asthma, Psychological Distress | Status: COMPLETED | Results posted: 2026-07-13